Conducting a phase III clinical trial of a COVID-19 drug
28 January 2021
CPD has received permission from the Russian Ministry of Health to conduct a phase III clinical trial of a promising broad-spectrum drug used in the treatment of patients with a new coronavirus infection (COVID-19) severe course and proceeds to organize the conduct of this study. Up to 350 patients will take part in the study.